SEC Form 4 · accession 0000899243-18-014929
AILERON THERAPEUTICS INC · ALRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Donald Dougherty
Officer — SVP & Chief Financial Officer
Period of report
Jun 1, 2018
Accepted (ET)
Jun 4, 2018 · 4:54 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420565
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 1, 2018 | P | 2,000 | $5.24 | A | 2,000 | D |
Table II — derivative securities
No Table II lines on this filing.